Home » Topics » Conferences

Conferences
RSS

Sanofi-Synthelabo's SR-58611 normalizes wound healing in diabetic and obese mice

July 6, 1999

CGP-3466B proves effective as neuropotectant both in vitro and in vivo

July 6, 1999

Anorexigenic cytokine gene therapy: a new approach to treating obesity

July 6, 1999

Recent advances in gene therapy of cystic fibrosis

July 6, 1999

Mechanism of action of new centrally acting muscle relaxant silperisone examined

July 6, 1999

Selective Genetics' GAM technology enhances delivery and retention of NTF gene therapy

July 6, 1999

Chiron develops novel gene therapy for degenerative retinal disorders

July 6, 1999

Allotrap-1258, a rationally designed immunomodulating peptide for the prevention of GvHD

July 6, 1999

Second-generation PDE4 inhibitors highlighted at World Congress on Inflammation

July 5, 1999

Noncompetitive AMPA receptor antagonist emerges as development candidate for stroke, epilepsy, etc.

July 5, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...